T1	Participants 63 90	chronic alcoholic patients.
T2	Participants 194 323	32 randomly selected hospitalized male alcoholic patients with clinical, biochemical and histological evidence of hepatic damage.
T3	Participants 1140 1168	ethanol-induced liver damage
T4	Participants 1222 1266	patients with alcoholic liver disease (ALD).
